Consistently, the levels of angiogenic factors, such as VEGF, IL-6, TSP-1, PF4, TGFβ, and PDGFβ were linked not only with the platelet count but also with cancer stage and patient prognosis [71,75,82,85,86,87,88,89,90]. This evidence concerns the gene THBS1 and cancer.